Skip to content

Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow Imaging

Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05270005
Acronym
CAS-PRO
Enrollment
85
Registered
2022-03-08
Start date
2022-04-07
Completion date
2026-12-01
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis

Keywords

Ultrafast ultrasound flow imaging, Atherosclerotic plaque, Disease progression, Velocity vector imaging

Brief summary

Rationale: Approximately 15-20% of strokes originates from an atherosclerotic plaque rupture in the carotid artery. To reduce the risk of stroke, patients should be evaluated for possible carotid endarterectomy (CEA), which is based on simple geometrical and clinical measures. Multiple studies have shown that the current risk stratification may lead to both over- and under-treatment for patients with carotid artery stenosis. This implicates that the current guidelines are lacking patient-specific parameters and have limited sensitivity. There is a wealth of evidence implicating the important role of local (disturbed) blood flow throughout the onset and progression of atherosclerosis. Novel flow-related measures, that go beyond simple geometrical indications, are required to improve diagnosis and treatment in patients with carotid artery stenosis. Nowadays, ultrasound (US) is one of the main techniques to assess for the presence and extent of carotid artery stenosis. However, current clinically-used US systems are unable to acquire and visualize the complex flow phenomena that play such a crucial role in the atherosclerotic disease process. With the advent of ultrafast ultrasound imaging, acquiring thousands of images per second, continuous tracking of flow in all directions became feasible, which enables us to image two-dimensional blood flow and possible disturbances with high accuracy and precision. In this project, we aim to assess whether flow (related) parameters are associated with disease progression (and if so, which), in order to map the progression of atherosclerotic plaques using non-invasive, US-based blood flow imaging. In the future, this could improve risk stratification for individual patients for surgery, decrease patient mortality and morbidity, and therefore reduce healthcare costs. Objective: To longitudinally assess the association between spatio-temporal blood flow velocities (peak systole and end-diastole at common carotid artery, maximum stenosis and internal carotid artery) and the progression of carotid atherosclerosis defined by duplex measurements. Secondary objectives are to investigate the association between blood flow-derived parameters, including wall shear stress (WSS), vector complexity and vorticity, and the progression of atherosclerosis defined by duplex measurements. Furthermore, to assess the association between spatio-temporal blood flow velocities and blood flow-derived parameters (WSS, vector complexity and vorticity) and the progression of atherosclerosis as measured using ultrasound-based strain imaging.

Interventions

Ultrasound-based flow imaging of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

DIAGNOSTIC_TESTUltrasound-based strain imaging

Ultrasound-based strain imaging of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

DIAGNOSTIC_TESTConventional duplex

Conventional duplex measurements of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

Sponsors

Radboud University Medical Center
CollaboratorOTHER
Rijnstate Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult male or female (≥18 years old); * Informed consent form understood and signed, and patient agrees to follow-up visits; * Presence of carotid artery stenosis (between 30%-69%) according to conventional duplex measurements (peak-systolic velocity of 125-230 cm/s \[5\] in combination with visible lumen reduction \>30% according to North American Symptomatic Carotid Endarterectomy Trial \[NASCET\] method); * Defined asymptomatic with respect to the ipsilateral carotid artery stenosis.

Exclusion criteria

* A planned carotid revascularisation for the ipsilateral carotid artery stenosis at date of inclusion; * History of carotid revascularisation at artery under investigation; * Visible near occlusion at asymptomatic stenosis side according to conventional duplex measurements; * Life expectancy \< 2 years; * Participating in another clinical study, interfering on outcomes

Design outcomes

Primary

MeasureTime frameDescription
Two-dimensional spatio-temporal blood flow velocities2 year follow-upTwo-dimensional vector velocity fields derived from the US-based flow imaging will be used to calculate the spatio-temporal blood flow velocities.
Plaque progression (stenosis degree)2 year follow-upPlaque progression, defined by increase in stenosis degree. Stenosis degree will be quantified by conventional ultrasound imaging.

Secondary

MeasureTime frameDescription
Vector complexity2 year follow-upMultiple blood flow-related parameters will be derived from the spatio-temporal blood flow velocity data. One parameter is vector complexity.
Wall shear stress2 year follow-upMultiple blood flow-related parameters will be derived from the spatio-temporal blood flow velocity data. One parameter is the wall shear stress.
Symptomatic carotid stenosis2 year follow-up
Plaque progression (deformation)2 year follow-upPlaque progression, defined by change in plaque deformation. Plaque deformation will be quantified by strain imaging.
Vorticity2 year follow-upMultiple blood flow-related parameters will be derived from the spatio-temporal blood flow velocity data. One parameter is vorticity.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026